Auto/Allo Tandem Transplant for Relapsed B-NHL

New York Medical College

Status: Completed

Conditions: Non Hodgkin Lymphoma

Treatments: Procedure: auto transplant followed by allo transplant

Study type: Observational

Funder types: Other

Identifiers

NCT03205657

L 11,813

Details and patient eligibility

About

The investigators plan to perform a retrospective review of patients with poor risk relapsed/refractory B-NHL having received HSCT and targeted immunotherapy at the Maria Fareri Children's Hospital between January 1, 2012 and June 1, 2015. The investigators will review the clinical records and collect the data with de-identified medical information from our HSCT clinical research database.

Full description

The investigators will obtain the following information from the patient's medical records: clinical factors including age at presentation, gender, clinical presentation, laboratory and pathology data, lymphoma diagnosis, clinical staging criteria, anti-cancer therapy as well as supportive care medicines, complications of therapy (adverse events graded from CTCAE v4.0), and hematopoietic stem cell transplantation therapy (chemotherapy, donor source, cell dose), course (engraftment, GVHD, chimerism), and follow-up (disease status).

Enrollment: 12 patients

Sex: All

Ages: Under 29 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• This analysis will include all children, adolescents, and young adults less than 29 years old with a histologically confirmed diagnosis of B-NHL treated at the Maria Fareri Children's Hospital

Exclusion criteria

• None